How we work with your practice.

Pre-treatment workflow

From referral submission to first treatment, the typical timeline is 5 to 10 business days. Here is what happens, and when:

• Day 0 (referral received): Same-day acknowledgment email to your office. Multidisciplinary care team assigned. Patient outreach initiated within 24 hours.
• Day 1 to 2: Benefits investigation completed. Prior authorization submission to insurer if required.
• Day 2 to 7: Prior authorization approval (varies by payor; we expedite where possible). Patient scheduling for first appointment or first delivery.
• Day 5 to 10: First treatment delivered. Post-treatment summary sent to your office.

Urgent referrals are expedited. Same-day initiation is possible when prior authorization is not required and inventory is available.

Communication standards

Your office receives standardized updates at four points in the patient journey:

1. Intake summary — within 48 hours of referral. Includes benefits verification status, prior auth status, scheduled start date.
2. First treatment confirmation — within 24 hours of first dose. Includes clinical observations, any reactions, next-dose schedule.
3. Quarterly therapy review — adherence summary, lab coordination requests, dose-modification recommendations if applicable.
4. Adverse event escalation — within 1 hour of any clinically significant adverse event. Direct phone contact with prescribing physician for serious AEs.

Refill and adherence management

For specialty pharmacy patients, refills are managed automatically by the assigned PharmD. We track adherence and flag patterns: missed doses, late refills, or premature refills that may suggest dose-related issues. Your office receives a brief adherence report quarterly, with immediate notification if a patient appears to have lapsed therapy entirely.

Lab coordination

For therapies that require routine lab monitoring (TB screening for biologics, CBC for certain MS therapies, liver function for JAK inhibitors), TheraVite coordinates with your office to ensure labs are obtained at appropriate intervals. We do not order labs ourselves — your office maintains the prescribing relationship — but we track results and remind your office when labs are due.

Adverse event handling

Our protocols follow the standard IV biologic AE management framework, escalating from mild (in-suite management, document, continue therapy) to moderate (pause infusion, premedicate, consult prescriber) to severe (stop infusion, emergency response, immediate prescriber notification). All AEs are documented per FDA MedWatch standards and reported to manufacturers as required.

Patient transitions

Patients frequently transition between specialty pharmacies, between infusion centers, or between IV and self-injection of the same therapy. TheraVite handles all of these:

• Transfer-in from another specialty pharmacy: we obtain prior PA documentation, current refill status, and any clinical notes from the prior pharmacy.
• Transfer-out to another provider: we provide a complete therapy summary including AE history and adherence data.
• IV to self-injection: for therapies available in both forms (Humira, for example), our pharmacists handle the prescription transition and patient training.

Documentation and EHR integration

TheraVite’s standard documentation flows by secure fax or HIPAA-compliant email to your office. Direct EHR integration (Epic, Cerner, Athena) is available for higher-volume referring practices — please contact us to discuss.